Federico Grossi - 01 Dec 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Chief Medical Officer
Signature
/s/ David Watson, attorney-in-fact for Federico Grossi
Issuer symbol
APLS
Transactions as of
01 Dec 2022
Net transactions value
-$124,825
Form type
4
Filing time
02 Dec 2022, 15:30:29 UTC
Previous filing
03 Nov 2022
Next filing
09 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Sale $124,825 -2,500 -2.5% $49.93 97,384 01 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected by pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 25, 2022.